We will discuss current research in the following three areas: 1) mapping metabolic drivers of human diseases using chemoproteomic and metabolomic platforms; 2) expanding the druggable proteome through mapping and pharmacologically interrogating proteome-wide hyper-reactive and ligandable hotspots; 3) mapping proteome-wide targets of environmental and pharmaceutical chemicals towards understanding novel toxicological mechanisms.

Repeat Rules